Endoscopic ultrasonography-guided ablation therapy.
Trevino JM, Varadarajulu S.
J Hepatobiliary Pancreat Sci. 2011 May;18(3):304-10. doi: 10.1007/s00534-010-0352-7.
A randomized controlled trial to evaluate the safety and efficacy of transluminal injection of foam sclerotherapy compared with ultrasound-guided foam sclerotherapy during endovenous catheter ablation in patients with varicose veins.
Watanabe S, Okamura A, Iwamoto M, Nagai H, Sumiyoshi A, Tanaka K, Suzuki S, Tanaka H, Iwakura K, Fujii K.
J Vasc Surg Venous Lymphat Disord. 2022 Jan;10(1):75-81.e1. doi: 10.1016/j.jvsv.2021.06.017. Epub 2021 Jul 10.
New technologies for the treatment of obstructive arterial disease.
Fischell TA, Stadius ML.
Cathet Cardiovasc Diagn. 1991 Mar;22(3):205-33. doi: 10.1002/ccd.1810220311.
Clinical Effect of the Modified Morrow Septal Myectomy Procedure for Biventricular Hypertrophic Cardiomyopathy.
Tan T, Zhu W, Ma J, Fu B, Zeng X, Wang R, Li X, Liu J, Zhuang J, Chen J, Guo H.
Rev Cardiovasc Med. 2024 Jan 10;25(1):21. doi: 10.31083/j.rcm2501021. eCollection 2024 Jan.
International expert consensus statement: Percutaneous transluminal renal denervation for the treatment of resistant hypertension.
Schlaich MP, Schmieder RE, Bakris G, Blankestijn PJ, Böhm M, Campese VM, Francis DP, Grassi G, Hering D, Katholi R, Kjeldsen S, Krum H, Mahfoud F, Mancia G, Messerli FH, Narkiewicz K, Parati G, Rocha-Singh KJ, Ruilope LM, Rump LC, Sica DA, Sobotka PA, Tsioufis C, Vonend O, Weber MA, Williams B, Zeller T, Esler MD.
J Am Coll Cardiol. 2013 Dec 3;62(22):2031-45. doi: 10.1016/j.jacc.2013.08.1616. Epub 2013 Sep 18.
What the interventionalist should know about renal denervation in hypertensive patients: a position paper by the ESH WG on the interventional treatment of hypertension.
Tsioufis C, Mahfoud F, Mancia G, Redon J, Damascelli B, Zeller T, Schmieder RE.
EuroIntervention. 2014 Jan 22;9(9):1027-35. doi: 10.4244/EIJV9I9A175.
Percutaneous transluminal septal ablation in hypertrophic obstructive cardiomyopathy.
Seggewiss H, Faber L, Gleichmann U.
Thorac Cardiovasc Surg. 1999 Apr;47(2):94-100. doi: 10.1055/s-2007-1013118.
Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute results and 3-month follow-up in 25 patients.
Seggewiss H, Gleichmann U, Faber L, Fassbender D, Schmidt HK, Strick S.
J Am Coll Cardiol. 1998 Feb;31(2):252-8. doi: 10.1016/s0735-1097(97)00508-1.
Severe bilateral renal artery stenosis after transluminal radiofrequency ablation of renal sympathetic nerve plexus.
Chandra AP, Marron CD, Puckridge P, Spark JI.
J Vasc Surg. 2015 Jul;62(1):222-5. doi: 10.1016/j.jvs.2013.11.005. Epub 2014 Jan 24.
Transluminal radiofrequency tissue ablation with use of metallic stents.
Goldberg SN, Ryan TP, Hahn PF, Schima W, Dawson SL, Lawes KR, Mueller PR, Gazelle GS.
J Vasc Interv Radiol. 1997 Sep-Oct;8(5):835-43. doi: 10.1016/s1051-0443(97)70669-9.
